Net profit of Pfizer rose 19.37% to Rs 189.02 crore in the quarter ended September 2025 as against Rs 158.35 crore during the previous quarter ended September 2024. Sales rose 9.13% to Rs 642.34 crore in the quarter ended September 2025 as against Rs 588.59 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales642.34588.59 9 OPM %35.8032.15 - PBDT269.65230.22 17 PBT255.37215.23 19 NP189.02158.35 19 Powered by Capital Market - Live News

Pfizer will hold a meeting of the Board of Directors of the Company on 12 November 2025.Powered by Capital Market - Live News

Net profit of Pfizer rose 27.23% to Rs 191.75 crore in the quarter ended June 2025 as against Rs 150.71 crore during the previous quarter ended June 2024. Sales rose 7.14% to Rs 603.05 crore in the quarter ended June 2025 as against Rs 562.86 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales603.05562.86 7 OPM %34.8331.53 - PBDT273.94217.22 26 PBT259.53202.62 28 NP191.75150.71 27 Powered by Capital Market - Live News

Pfizer will hold a meeting of the Board of Directors of the Company on 13 August 2025.Powered by Capital Market - Live News

Pfizer announced that the 74th Annual General Meeting(AGM) of the company will be held on 21 July 2025.Powered by Capital Market - Live News